Boehringer Ingelheim, Roche Partnering on New Class of Bowel Disease Therapies
Vetera 5XP (2-way Sleeping Sickness + Tet + Flu + Rhino) Equine Vaccine Boehringer Ingelheim - Combi $31
Boehringer Ingelheim, Certificate Design, Arquitetura, Tiling, Products, Interiors
The secondary endpoints for efficacy, safety and immunogenicity of BI 695501 vs. Humira, were also met.
Boehringer Ingelheim, Idiopathic Pulmonary Fibrosis, Asthma